Corrigendum: Development of phage cocktails to treat E. coli catheter-associated urinary tract infection and associated biofilms.

Autor:	Sanchez BC; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States., Heckmann ER; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States., Green SI; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States., Clark JR; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States., Kaplan HB; Department of Microbiology and Molecular Genetics, McGovern Medical School, UTHealth Houston, Houston, TX, United States., Ramig RF; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States., Muldrew KL; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.; Pathology and Laboratory Medicine, Michael E. DeBakey VA Medical Center, Houston, TX, United States.; Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, United States., Hines-Munson C; Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, TX, United States., Skelton F; Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, TX, United States.; H. Ben Taub Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, TX, United States., Trautner BW; Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, TX, United States.; Department of Medicine and Surgery, Baylor College of Medicine, Houston, TX, United States.; Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey VA Medical Center, Houston, TX, United States., Maresso AW; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States.
Jazyk:	angličtina
Zdroj:	Frontiers in microbiology [Front Microbiol] 2022 Aug 09; Vol. 13, pp. 953136. Date of Electronic Publication: 2022 Aug 09 (Print Publication: 2022).
DOI:	10.3389/fmicb.2022.953136
Abstrakt:	[This corrects the article DOI: 10.3389/fmicb.2022.796132.]. (Copyright © 2022 Sanchez, Heckmann, Green, Clark, Kaplan, Ramig, Muldrew, Hines-Munson, Skelton, Trautner and Maresso.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu